Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

Appropriately aggregate holistic technologies via accurate expertise. Intrinsicly strategize worldwide initiatives and premium methodologies.

Dissection-independent production of Plasmodium sporozoites from whole mosquitoes.

Blight J. et al, (2021), Life science alliance, 4

Type of RNA Packed in VLPs Impacts IgG Class Switching—Implications for an Influenza Vaccine Design

C. Gomes A. et al, (2019), Vaccines, 7, 47 - 47

Correction to: Vaccination with nanoparticles combined with micro-adjuvants protects against cancer.

Mohsen MO. et al, (2019), Journal for immunotherapy of cancer, 7

Active immunisation targeting nerve growth factor attenuates chronic pain behaviour in murine osteoarthritis

von Loga IS. et al, (2019), Annals of the Rheumatic Diseases, 78, 672 - 675

Vaccination with nanoparticles combined with micro-adjuvants protects against cancer.

Mohsen MO. et al, (2019), Journal for immunotherapy of cancer, 7

Targeting Mutated Plus Germline Epitopes Confers Pre-clinical Efficacy of an Instantly Formulated Cancer Nano-Vaccine.

Mohsen MO. et al, (2019), Frontiers in immunology, 10

The Prospects of an Active Vaccine Against Asthma Targeting IL-5

Bachmann MF. et al, (2018), Frontiers in Microbiology, 9

Active and Passive Immunization Against Type 2 Diabetes Mellitus

Roesti E. et al, (2018), SWISS MEDICAL WEEKLY, 148, 35S - 36S

Mutated as well as germ-line epitopes contribute to preclinical efficacy of virus-like particles based cancer vaccines

Mohsen MO. et al, (2018), SWISS MEDICAL WEEKLY, 148, 34S - 34S

Vaccination against nerve growth factor is an effective pain treatment in murine osteoarthritis

von Loga IS. et al, (2018), Osteoarthritis and Cartilage, 26, S355 - S355

Noninfectious Disease Vaccines

El-Turabi A. and Bachmann MF., (2018), Plotkin's Vaccines, 689 - 697.e4

Incorporation of tetanus-epitope into virus-like particles achieves vaccine responses even in older recipients in models of psoriasis, Alzheimer’s and cat allergy

Zeltins A. et al, (2017), npj Vaccines, 2

Preclinical development of a vaccine against oligomeric alpha-synuclein based on virus-like particles

Doucet M. et al, (2017), PLOS ONE, 12, e0181844 - e0181844

Microcrystalline Tyrosine (MCT): a depot adjuvant used in allergy offers new opportunities in infectious disease

Cabral-Miranda G. et al, (2017), ALLERGY, 72, 201 - 201

Accelerating the clinical development of protein-based vaccines for malaria by efficient purification using a four amino acid C-terminal ‘C-tag’

Jin J. et al, (2017), International Journal for Parasitology, 47, 435 - 446

Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivax

Cabral-Miranda G. et al, (2017), Vaccines, 5, 10 - 10

Evaluation of Plasmodium vivax Cell-Traversal Protein for Ookinetes and Sporozoites as a Preerythrocytic P. vivax Vaccine

Alves E. et al, (2017), Clinical and Vaccine Immunology, 24

Adjusted Particle Size Eliminates the Need of Linkage of Antigen and Adjuvants for Appropriated T Cell Responses in Virus-Like Particle-Based Vaccines

Gomes AC. et al, (2017), Frontiers in Immunology, 8

Tandem Fusion of Hepatitis B Core Antigen Allows Assembly of Virus-Like Particles in Bacteria and Plants with Enhanced Capacity to Accommodate Foreign Proteins

Peyret H. et al, (2015), PLOS ONE, 10, e0120751 - e0120751

A DUAL INSERT HEPATITIS B TANDEM CORE VACCINE ELICITS STRONG HBV IMMUNE RESPONSES AND SIMULTANEOUSLY CONFERS PROTECTIVE IMMUNITY IN AN INFLUENZA MODEL

Whelan M. et al, (2010), HEPATOLOGY, 52, 534A - 534A

Include forthcoming?